Page last updated: 2024-09-03

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and arginine vasopressin

1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin has been researched along with arginine vasopressin in 28 studies

Compound Research Comparison

Studies
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)
Trials
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)
Recent Studies (post-2010)
(1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin)
Studies
(arginine vasopressin)
Trials
(arginine vasopressin)
Recent Studies (post-2010) (arginine vasopressin)
280012,2784221,212

Protein Interaction Comparison

ProteinTaxonomy1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin (IC50)arginine vasopressin (IC50)
Vasopressin V2 receptorHomo sapiens (human)0.242

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-199013 (46.43)18.7374
1990's13 (46.43)18.2507
2000's2 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T1
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C1
Joran, ME; Murphy, DJ1
Campochiaro, PA; Delahunty, TM; Friedman, Z; Linden, J1
Campbell, GK; DiMartino, MJ; Gabel, RA; Hanna, N; Macia, RA; Silver, AC1
Brooks, VL; Hatton, DC1
Brooks, DP; Caldwell, N; Caltabiano, S; Huffman, WF; Kinter, LB; Winslow, C1
Holmes, MM; Lantos, I; Mendelson, WL; Tickner, AM1
Ashton, D; Dytko, G; Huffman, W; Kinter, LB; McDonald, J; Stassen, F1
Albrightson-Winslow, C; Brickson, B; Bryan, HG; Caldwell, N; Dytko, G; Eggleston, DS; Huffman, WF; Kinter, LB; Moore, ML; Newlander, KA1
Albrightson-Winslow, CR; Brooks, DP; Caldwell, N; Huffman, WF; Kinter, LB; Stassen, FL1
Ashton, N; Balment, RJ1
Garvie, CT; Rhodes, GR; Rubenfield, MJ1
Guyenet, PG; Sun, MK1
Berkowitz, BA; Ohlstein, EH1
Aiyar, N; Crooke, ST; Heckman, G; Landvatter, S; Nambi, P; Schmidt, D; Stassen, FL1
Aiyar, N; Crooke, ST; Nambi, P; Stassen, FL1
Albrightson, CR; Brooks, DP; Huffman, WF; Kinter, LB; Koster, PF; Stassen, FL; Wasserman, MA1
Kinter, LB; Liversidge, GG; Sternson, WL; Wilson, CG1
Albrightson-Winslow, CR; Brooks, DP; Huffman, WF; Kinter, LB; Koster, PF; Stassen, FL1
Holland, GA; Kinter, LB; Lenkinski, RE; Mattingly, MA; Sarkar, SK1
Aldasoro, M; Flor, B; Lluch, S; Martínez, MC; Medina, P; Vila, JM1
Bernardini, R; Chiarenza, A; Chrousos, GP; Demitrack, M; Gold, PW; Kamilaris, TC; Lempereur, L; Renaud, N1
Summerlee, AJ; Wilson, BC1
Divers, T; Huffman, WF; Kinter, LB; Monaghan, ML1
Caltabiano, S; Huffman, WF; Kinter, LB1
Antunes-Rodrigues, J; Branco, LG; Carnio, EC; Steiner, AA1
Angers, S; Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Laperrière, A; Lonergan, M; Morello, JP; Morin, D; Petäjä-Repo, U; Salahpour, A1

Reviews

1 review(s) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and arginine vasopressin

ArticleYear
Anomalous antidiuretic activity of antidiuretic hormone antagonists.
    Biochemical pharmacology, 1993, May-05, Volume: 45, Issue:9

    Topics: Animals; Arginine Vasopressin; Binding, Competitive; Deamino Arginine Vasopressin; Diuresis; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Receptors, Vasopressin; Species Specificity; Up-Regulation; Vasopressins

1993

Other Studies

27 other study(ies) available for 1-((beta-mercapto-beta)beta cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-9-des-gly-arginine vasopressin and arginine vasopressin

ArticleYear
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    British journal of pharmacology, 1998, Volume: 125, Issue:7

    Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium

1998
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
    Kidney international, 2000, Volume: 58, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance

2000
Respiratory and cardiovascular changes associated with toxic doses of a peptide antagonist of vasopressin in the rat.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1992, Volume: 18, Issue:2

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular System; Male; Mast Cells; Peptides; Rats; Rats, Inbred Strains; Respiratory System; Vasopressins

1992
Human retinal pigment epithelial cells possess V1 vasopressin receptors.
    Current eye research, 1991, Volume: 10, Issue:9

    Topics: Aminoquinolines; Angiotensin Receptor Antagonists; Arginine Vasopressin; Calcium; Cells, Cultured; Cyclic AMP; Fluorescent Dyes; Humans; Inositol Phosphates; Pigment Epithelium of Eye; Receptors, Angiotensin; Receptors, Vasopressin; Spectrometry, Fluorescence; Vasopressins

1991
Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation.
    Toxicology and applied pharmacology, 1990, Volume: 102, Issue:1

    Topics: Animals; Arginine Vasopressin; Cell Degranulation; Edema; Hindlimb; Histamine Release; Hypotension; Male; Mast Cells; Rats; Rats, Inbred Strains; Time Factors; Vasopressins

1990
Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
    The American journal of physiology, 1991, Volume: 260, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Deamino Arginine Vasopressin; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Rate; Hypotension; Injections, Intravenous; Male; Nitroprusside; Norepinephrine; Receptors, Angiotensin; Receptors, Vasopressin; Sympathetic Nervous System; Vascular Resistance; Vasopressins

1991
Physiological regulation of the renal vasopressin receptor-effector pathway in dogs.
    The American journal of physiology, 1990, Volume: 258, Issue:3 Pt 2

    Topics: Animals; Arginine Vasopressin; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Kidney; Osmolar Concentration; Receptors, Angiotensin; Receptors, Vasopressin; Vasopressins

1990
Efficient solution phase synthesis of [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid)- 2-(O-ethyl-D-tyrosine)-4-valine-9-desglycine]arginine vasopressin.
    International journal of peptide and protein research, 1990, Volume: 35, Issue:3

    Topics: Amino Acid Sequence; Arginine Vasopressin; Azides; Chemical Phenomena; Chemistry; Disulfides; Iodine; Molecular Sequence Data; Oligopeptides; Solutions; Sulfhydryl Compounds; Vasopressins

1990
Discovery and therapeutic utility of vasopressin antagonists in rats.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 7

    Topics: Animals; Arginine Vasopressin; Dehydration; Diuresis; Dose-Response Relationship, Drug; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Shock, Septic; Vasopressins

1986
A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Amino Acid Sequence; Animals; Arginine Vasopressin; Binding, Competitive; Biological Assay; Blood; Chemical Phenomena; Chemistry; Dogs; Humans; Kidney Medulla; Molecular Conformation; Osmolar Concentration; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Stereoisomerism; Structure-Activity Relationship; Swine; Urine; Vasopressins

1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 249, Issue:2

    Topics: Animals; Arginine Vasopressin; Cyclooxygenase Inhibitors; Dinoprostone; Diuresis; Dogs; Dose-Response Relationship, Drug; Female; Indomethacin; Prostaglandins; Receptors, Angiotensin; Receptors, Vasopressin

1989
Renal and blood pressure changes in response to vasopressin antagonism in the New Zealand genetically hypertensive rat.
    Acta endocrinologica, 1989, Volume: 120, Issue:5

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Urination; Water-Electrolyte Balance

1989
Determination of a disulfide-containing octapeptide antagonist of vasopressin in human plasma utilizing high-performance liquid chromatography with fluorescence detection.
    Journal of chromatography, 1989, Mar-24, Volume: 488, Issue:2

    Topics: Arginine Vasopressin; Chromatography, High Pressure Liquid; Humans; Spectrometry, Fluorescence

1989
Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons 'in vitro'.
    Brain research, 1989, Jul-17, Volume: 492, Issue:1-2

    Topics: Action Potentials; Adrenergic Fibers; Animals; Arginine Vasopressin; In Vitro Techniques; Medulla Oblongata; Neuropeptides; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin

1989
Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 239, Issue:3

    Topics: Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Kinetics; Mesenteric Arteries; Norepinephrine; Receptors, Angiotensin; Receptors, Vasopressin; Tachyphylaxis; Vasoconstriction

1986
A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Molecular pharmacology, 1987, Volume: 31, Issue:3

    Topics: Animals; Arginine Vasopressin; Binding, Competitive; Cell Line; Cell Membrane; Dogs; Guanylyl Imidodiphosphate; Kidney; Kinetics; Liver; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Receptors, Vasopressin

1987
Effects of N-ethylmaleimide on arginine vasopressin-induced responses in an established smooth muscle cell line.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:1

    Topics: Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium; Cell Membrane; Ethylmaleimide; GTP Phosphohydrolases; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Male; Muscle, Smooth, Vascular; Phosphatidylinositols; Rats

1987
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
    British journal of pharmacology, 1988, Volume: 94, Issue:3

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Deamino Arginine Vasopressin; Disease Models, Animal; Flushing; Heart Rate; Hemodynamics; Indomethacin; Macaca mulatta; Male

1988
Nasal delivery of a vasopressin antagonist in dogs.
    Journal of applied physiology (Bethesda, Md. : 1985), 1988, Volume: 64, Issue:1

    Topics: Administration, Intranasal; Aerosols; Animals; Arginine Vasopressin; Biological Availability; Dogs; Dosage Forms; Female; Injections, Intravenous; Metabolic Clearance Rate; Nasal Cavity; Organometallic Compounds; Pentetic Acid; Technetium Tc 99m Pentetate

1988
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:1

    Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Dogs; Female; Humans; Kidney; Macaca mulatta; Natriuresis; Rats; Saimiri; Vasopressins

1988
Renal imaging studies at 1.5 and 9.4 T: effects of diuretics.
    Magnetic resonance in medicine, 1988, Volume: 7, Issue:1

    Topics: Animals; Arginine Vasopressin; Diuretics; Furosemide; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Rats; Rats, Inbred Strains

1988
Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
    British journal of pharmacology, 1994, Volume: 113, Issue:2

    Topics: Adult; Arginine; Arginine Vasopressin; Deamino Arginine Vasopressin; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasopressins

1994
In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Neuroendocrinology, 1994, Volume: 60, Issue:5

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Hypothalamus; In Vitro Techniques; Injections, Intravenous; Kinetics; Male; Pituitary Gland; Rats; Rats, Sprague-Dawley

1994
Effects of exogenous relaxin on oxytocin and vasopressin release and the intramammary pressure response to central hyperosmotic challenge.
    The Journal of endocrinology, 1994, Volume: 141, Issue:1

    Topics: Animals; Arginine Vasopressin; Female; Hypertonic Solutions; Lactation; Mammary Glands, Animal; Osmolar Concentration; Oxytocin; Pregnancy; Pressure; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Relaxin; Sodium Chloride; Stimulation, Chemical; Time Factors; Vasopressins

1994
Antagonism of antidiuretic hormone in domestic pigs (Sus scrofa).
    General pharmacology, 1993, Volume: 24, Issue:4

    Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Diuresis; Drinking Behavior; Electrolytes; Female; In Vitro Techniques; Kidney Concentrating Ability; Kidney Medulla; Lypressin; Osmolar Concentration; Swine; Vasopressins

1993
Role of nitric oxide in systemic vasopressin-induced hypothermia.
    The American journal of physiology, 1998, Volume: 275, Issue:4

    Topics: Animals; Arginine Vasopressin; Body Temperature; Body Temperature Regulation; Cerebral Ventricles; Hormone Antagonists; Hypothermia, Induced; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar

1998
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:7

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Cell Line; Cell Membrane; COS Cells; Diabetes Insipidus, Nephrogenic; Flow Cytometry; Humans; Intracellular Fluid; Molecular Chaperones; Morpholines; Mutagenesis; Protein Folding; Pyrroles; Receptors, Vasopressin; Spiro Compounds

2000